715 related articles for article (PubMed ID: 29562882)
21. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
[TBL] [Abstract][Full Text] [Related]
22. T cell epitopes and post-translationally modified epitopes in type 1 diabetes.
McGinty JW; Marré ML; Bajzik V; Piganelli JD; James EA
Curr Diab Rep; 2015 Nov; 15(11):90. PubMed ID: 26370701
[TBL] [Abstract][Full Text] [Related]
23. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
24. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
[TBL] [Abstract][Full Text] [Related]
25. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
26. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
27. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8.
Li S; Li H; Chen B; Lu D; Deng W; Jiang Y; Zhou Z; Yang Z
Vaccine; 2013 Mar; 31(12):1610-5. PubMed ID: 23246542
[TBL] [Abstract][Full Text] [Related]
29. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
Dhiman G; Lohia N; Jain S; Baranwal M
Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
[TBL] [Abstract][Full Text] [Related]
30. Proteasome-Generated
Mansurkhodzhaev A; Barbosa CRR; Mishto M; Liepe J
Front Immunol; 2021; 12():614276. PubMed ID: 33717099
[TBL] [Abstract][Full Text] [Related]
31. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
32. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
[TBL] [Abstract][Full Text] [Related]
34. Post-Translational Peptide Splicing and T Cell Responses.
Mishto M; Liepe J
Trends Immunol; 2017 Dec; 38(12):904-915. PubMed ID: 28830734
[TBL] [Abstract][Full Text] [Related]
35. Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.
Mei S; Ayala R; Ramarathinam SH; Illing PT; Faridi P; Song J; Purcell AW; Croft NP
Mol Cell Proteomics; 2020 Jul; 19(7):1236-1247. PubMed ID: 32357974
[TBL] [Abstract][Full Text] [Related]
36. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
Lee MN; Meyerson M
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
[TBL] [Abstract][Full Text] [Related]
37. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
38. Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.
Xu X; Gu Y; Bian L; Shi Y; Cai Y; Chen Y; Chen H; Qian L; Wu X; Xu K; Mallone R; Davidson HW; Yu L; She J; Zhang M; Yang T
Vaccine; 2016 Feb; 34(6):854-62. PubMed ID: 26541133
[TBL] [Abstract][Full Text] [Related]
39. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
40. CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.
Ou D; Jonsen LA; Metzger DL; Tingle AJ
Hum Immunol; 1999 Aug; 60(8):652-64. PubMed ID: 10439311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
